ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (NYSE Amex:RGN) (“the Company” or “RegeneRx”) today announced that R. Don Elsey has been appointed to the Company’s board of directors, effective September 1. Mr. Elsey will serve on the compensation and audit committees of the board of directors.
